There was a time when China's real estate insiders used to feel their sector was treated like a chamber pot - used opportunistically during economically unpleasant times, only to be cast aside irreverently, even disdainfully, later.
Shanghai's new sci-tech STAR Market, which is compared to Nasdaq, got off to a sparkling debut on July 22, but the real deal for long-term investors is in the deeper market-based reforms the new board seeks to advance.
Foreign companies need to seize the opportunities to adapt to the new direction of China's industrial restructuring. This they have to do while adjusting the strategic layout for future investment in the country. For, the Chinese economy will continue to fare well despite external uncertainties.
What's it to be as you go into that good night? Hours of ungentle carousing in a manner Dylan Thomas would have approved of? Or of something with a little more sobriety: imbibing fine writing that flows from the shelves of a nearby bookshop, something the Welsh poet might not have been averse to either?
China will step up efforts to bolster the platform economy, including ride-hailing, e-commerce and industrial internet, as part of the efforts to nurture new economic drivers, top industry officials said on Thursday.
The United States' labeling of China as a currency manipulator is unlikely to compel the International Monetary Fund to intervene, as it concluded recently that China's currency practices are in line with its economic fundamentals, according to experts.
Advanced technologies including 3D printing, 5G and artificial intelligence will become an inevitable trend of China's health industry whose market value will reach 20 trillion yuan ($2.84 trillion) by 2030, an industry expert said.
United Kingdom-based Herbert Smith Freehills said on Wednesday that it has become the sixth international law firm to be given approval to operate in the Shanghai Pilot Free Trade Zone after joining hands with Shanghai-based Kewei Law Firm.
Riding on the Belt and Road Initiative (BRI), Hong Kong-based enterprises are keenly eying investment opportunities in both Kenya and Djibouti.
Four years ago, US-based global management consulting company Oliver Wyman launched an aggressive expansion into the Chinese market, including the manufacturing, aviation and energy sectors, with a particular focus on retail and consumer goods.
Japanese biopharmaceutical company Takeda Pharmaceutical Co Ltd completed the purchase of Shire Plc in January, making rare diseases another key business area in addition to oncology, gastroenterology, and neuroscience among others in the company's global business blueprint.
|
|
|
|
|
|
|
|
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263 Registration Number: 20100000002731 
Raymond Zhou
Op Rana
Berlin Fang
Zhu Yuan
Huang Xiangyang
Chen Weihua
